Target intelligence / Profile preview

VDAC2 pseudogene 3 (VDAC2P3)

Target
VDAC2P3
Molecular classification
Other (Pseudogene)
01

Overview

VDAC2 pseudogene 3 (VDAC2P3) is a human pseudogene resembling the genomic structure of the VDAC2 gene, which encodes the voltage-dependent anion channel protein 2, but VDAC2P3 is non-coding and does not produce a functional protein. No expression or biological function has been documented for VDAC2P3, and there is no evidence linking it to human disease or therapeutic interventions. It is considered a processed or unprocessed genomic relic without current biomedical relevance[4]. Key clarifications: - This gene is not the same as the functional "Voltage-dependent anion-selective channel protein 2" (VDAC2). - There are multiple VDAC pseudogenes in the human genome, but VDAC2P3 is not expressed or functionally characterized. - All reported molecular functions, disease roles, or drug interactions for the VDAC2 gene do not apply to this pseudogene form[4]. Summary: VDAC2P3 is not a protein-coding gene, is not a therapeutic target, and should not be confused with the functional VDAC2 channel protein[4].

02

Mechanism of action

None (not a functional protein/receptor/enzyme/transporter, etc.)

03

Biological functions

None (pseudogene; lacks biological function as a protein)
04

Disease associations

None directly; no evidence for involvement in disease or as a biomarker[4]
05

Safety considerations

None (no functional activity, so not a therapeutic target)

Beyond the preview

Go deeper on VDAC2 pseudogene 3 (VDAC2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VDAC2 pseudogene 3 (VDAC2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call